Figure 9From: Oral administration of cytosolic PLA2 inhibitor arachidonyl trifluoromethyl ketone ameliorates cauda equina compression injury in ratsSchematic showing the hypothesized LSS-mediated events leading to activation of cPLA2, production of injurious lipids and induction of inflammation pain and motor function deficit. ATK treatment of CEC ameliorates LSS injury by inhibiting the activity of cPLA2.Back to article page